机译:头孢唑普兰在日本成年患者中的药代动力学药效学目标分析
Department of Clinical Pharmacotherapy Graduate School of Biomedical Sciences Hiroshima University 1-2-3 Kasumi Minami-ku Hiroshima 734-8551 Japan;
Department of Hematology and Oncology Kyoto Prefectural University of Medicine Kyoto Japan;
Department of Clinical Pharmacotherapy Graduate School of Biomedical Sciences Hiroshima University 1-2-3 Kasumi Minami-ku Hiroshima 734-8551 Japan;
Department of Clinical Pharmacotherapy Graduate School of Biomedical Sciences Hiroshima University 1-2-3 Kasumi Minami-ku Hiroshima 734-8551 Japan;
Department of Surgery Graduate School of Biomedical Sciences Hiroshima University Hiroshima Japan;
Department of Surgery Graduate School of Biomedical Sciences Hiroshima University Hiroshima Japan;
Department of Hematology and Oncology Kyoto Prefectural University of Medicine Kyoto Japan;
Cefozopran; Pharmacokinetics; Pharmacodynamics; Monte Carlo simulation; Dosing regimen;
机译:头孢唑普兰在日本成年患者中的药代动力学-药效学目标达成分析。
机译:比阿培南在成年患者中的药代动力学-药效学目标实现分析:一种给药策略。
机译:通过血浆和尿液浓度数据的药代动力学-药效学目标达到分析优化亚胺培南方案治疗肾功能不全患者
机译:与1型糖尿病的青少年过渡到青少年:日本Morioka地区的青少年和年轻患者的结构化支持辅助工具
机译:根据2017年日本成人白血病研究组(JALSG)AML201研究治疗的成人急性髓性白血病患者的遗传学预测,根据2017 ELN风险分层进行预后分析
机译:药物动力学-药效学目标达成分析以支持VL-2397剂量选择用于侵袭性曲霉病患者的2期试验
机译:药代动力学药物动力学靶率达到分析,支持VL-2397剂量选择侵袭性曲柄症患者的2阶段试验